Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127955081 | 12795508 | 1 | I | 20150916 | 20160929 | 20160929 | PER | CA-SEBELA IRELAND LIMITED-2016SEB00107 | SEBELA | 44.00 | YR | F | Y | 0.00000 | 20160929 | OT | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127955081 | 12795508 | 1 | PS | ALLOPURINOL. | ALLOPURINOL | 1 | 100 MG, DAILY | Y | 16084 | 100 | MG | TABLET | QD | ||||||
127955081 | 12795508 | 2 | SS | AZATHIOPRINE. | AZATHIOPRINE | 1 | 250 MG, UNK | Y | 0 | 250 | MG | ||||||||
127955081 | 12795508 | 3 | SS | AZATHIOPRINE. | AZATHIOPRINE | 1 | 50 MG, UNK | Y | 0 | 50 | MG | ||||||||
127955081 | 12795508 | 4 | SS | AZATHIOPRINE. | AZATHIOPRINE | 1 | 125 MG, UNK | Y | 0 | 125 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127955081 | 12795508 | 1 | Product used for unknown indication |
127955081 | 12795508 | 2 | Product used for unknown indication |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127955081 | 12795508 | Drug reaction with eosinophilia and systemic symptoms | |
127955081 | 12795508 | Eosinophilia | |
127955081 | 12795508 | Hepatic neoplasm | |
127955081 | 12795508 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |